Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers discover mechanism that may enable stem cell-based treatment for eye disorders

27.06.2005


UCI study shows how newly identified signaling protein helps control retinal development



In discovering a protein that helps organize the development of the retina, UC Irvine researchers have found a new molecular mechanism that may allow for stem cell-based therapies to treat eye disorders such as retinal degeneration.

The finding also reveals how the retina’s own stem cells can be directed to aid the growth of new cells to replace diseased or dying ones in the eye. Study results appear in the June 24 issue of the journal Science.


Anne L. Calof in the Department of Anatomy and Neurobiology and her UCI colleagues have identified how a protein called GDF11 controls a key component of retinal-cell differentiation during development, which makes GDDF11 an attractive therapeutic target.

"By manipulating the ability of this protein to control cell development, there is the potential for therapeutics to harness the power of the stem cells that already exist in the retina to replace any retinal cells that have been lost or injured," Calof said. "If so, we thereby may be able to cure visual disorders that result from loss of certain retinal cell types."

During the process of embryonic development, groups of neural precursor cells, which are formed from stem cells, are given brief periods of time to differentiate into their specific tissue forms, a process that is tightly regulated by signaling proteins.

In tests on developing mice, the Calof group observed that the GDF11 protein precisely controls the "window of opportunity" in which retinal precursor cells differentiate into the cells that give rise to the optic nerve. This regulation is important, Calof said, because it assures proper development of the entire retina, a nerve cell layer that lines the back of the eye, senses light and creates the electrical impulses that travel through the optic nerve to the brain.

GDF11 is part of the superfamily of TGF-beta proteins, which are widely studied for their role both in human development and in diseases like cancer. Because the structure and properties of these proteins are well known, GDF11 is an especially attractive target for potential drug treatments.

Therapies based on this protein become possible, Calof said, because the retina contains its own stem cells, which among other things, generate the photoreceptors that allow us to see color. However, harvesting these cells for therapeutic purposes may not be feasible. While researchers have created ways to extract adult stem cells from the body, the process is difficult and rarely successful.

Rather than removing adult stem cells and reintroducing cultured ones into the eye, Calof said, a drug therapy based on the GDF11 protein may be able to harness the power of these endogenous stem cells by directing the differentiation of these cells into specific retinal cell types.

"The ultimate goal is to control how GDF11 and related proteins regulate the window of opportunity for neural cell growth," Calof said. "If we or other researchers can accomplish this, we will come one step closer to understanding how to manipulate neural stem cells for therapeutic good."

The research was supported by the National Institutes of Health and the March of Dimes Birth Defects Foundation. Joon Kim, Hsiao-Huei Wu and Arthur Lander of UCI, along with Karen Lyons of UCLA and Martin M. Matzuk of Baylor College of Medicine, participated in the study. UCI has filed a patent for use of GDF11 and related proteins and antagonists in treatment of retinal disorders.

Tom Vasich | EurekAlert!
Further information:
http://www.uci.edu
http:// www.today.uci.edu

More articles from Studies and Analyses:

nachricht Antarctic Ice Sheet mass loss has increased
14.06.2018 | Technische Universität Dresden

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

Im Focus: Photoexcited graphene puzzle solved

A boost for graphene-based light detectors

Light detection and control lies at the heart of many modern device applications, such as smartphone cameras. Using graphene as a light-sensitive material for...

Im Focus: Water is not the same as water

Water molecules exist in two different forms with almost identical physical properties. For the first time, researchers have succeeded in separating the two forms to show that they can exhibit different chemical reactivities. These results were reported by researchers from the University of Basel and their colleagues in Hamburg in the scientific journal Nature Communications.

From a chemical perspective, water is a molecule in which a single oxygen atom is linked to two hydrogen atoms. It is less well known that water exists in two...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

A sprinkle of platinum nanoparticles onto graphene makes brain probes more sensitive

15.06.2018 | Materials Sciences

100 % Organic Farming in Bhutan – a Realistic Target?

15.06.2018 | Ecology, The Environment and Conservation

Perovskite-silicon solar cell research collaboration hits 25.2% efficiency

15.06.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>